News Alert

Maine Enacts 340B Contract Pharmacy Access Law with Added Hospital Reporting Requirements

Maine Gov. Janet Mills (D) on June 20 signed a budget bill with 340B contract pharmacy protections and expanded hospital reporting requirements.
Maine recently became the 20th state to enact a 340B contract pharmacy access law as part of a sweeping budget [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Rhode Island Passes Contract Pharmacy Access, Reporting Legislation, Sends to Governor

Rhode Island lawmakers on Friday passed contract pharmacy access legislation that contains provider reporting requirements and protections against alleged pharmacy benefit manager and insurer discriminatory practices.
Rhode Island lawmakers wrapped up their 2025 legislative session by passing contract pharmacy access bills that contain provider reporting requirements [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers, Hospital Group Appeal Dueling Aspects of 340B Rebate Ruling

Multiple drugmakers and an intervening hospital trade group are appealing different aspects of a federal district judge's ruling on 340B rebates.
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

The Compliance Arms Race: Can Smaller Covered Entities Keep Up?

SPONSORED CONTENT

The 340B program has morphed into a battlefield of rules, audits, and reporting. For smaller covered entities (CEs), especially rural hospitals and community clinics, keeping pace feels like a losing race. While large health systems deploy entire

Read More »

Q+A: Kalderos CEO Angie Franks Talks Truzo, 340B Program Transparency

Kalderos CEO Angie Franks recently spoke with 340B Report about the current battle over 340B rebate models, among other things.
Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump’s ‘Most Favored Nation’ Order Could Lower 340B Ceiling Prices, but Key Details Remain Unclear

President Donald Trump's "most favored nation" executive order has unclear effects on the 340B program.
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

NACHC Raises Concerns About 340B Rebates, Various Stakeholders Meet with Trump Administration on Rebate Guidance

NACHC raised concerns about implementing a 340B rebate model in a June 17 letter sent to CMS Administrator Mehmet Oz and HRSA Administrator Thomas Engels.
A national 340B community health center organization, which has faced criticism for its partnership with a powerful drug industry trade [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

AHA Report: 340B Hospitals Face More Federal Oversight, Fare Better in Audits; HRSA Releases Latest Drugmaker Audit

A new AHA analysis found that 340B hospitals face more federal oversight and routinely see higher rates of compliance in federal audits than drugmakers.
Hospitals that participate in the 340B program face more federal oversight and routinely see higher rates of compliance in federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Industry Insights Logo

A Neutral Clearinghouse: An Area of Potential Collaboration Between Covered Entities, Manufacturers and Payers

SPONSORED CONTENT

Drug manufacturers defend their unrelenting campaign to reform the 340B program by citing, among other things, the need to protect themselves from the problem of duplicate discounts.  Federal law affords such protection for drugs dispensed or administered to

Read More »

D.C. Federal District Court Dismisses Hospital Lawsuits Over J&J’s Controversial 340B Audit Requests

A Washington D.C. federal judge this week dismissed lawsuits Oregon Health & Science University and four other hospitals filed against HRSA for authorizing J&J to audit their 340B program records.
A Washington D.C. federal court this week threw out five hospital lawsuits challenging the Health Resources and Services Administration (HRSA) [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live